Keybanc Reiterates Rating on Janus Living, Inc. $JAN

Key Points

  • Keybanc now rates Janus Living, Inc. ($JAN) "buy" with a $29.00 target.
  • The Street's average $JAN price target is $29.50 (Buy).
  • $JAN last traded around $25.73.

Keybanc reiterated its rating on Janus Living, Inc. ($JAN) to a "buy" rating, with a price target of $29.00 in a recent research note.

Janus Living, Inc. ($JAN) Stock

Last price$25.73
Market cap$5.46B
Forward P/E86.43
52-week low$22.76
52-week high$28.52
50-day MA$25.73
200-day MA$25.38
Current ratio4.00
Quick ratio3.54

Janus Living, Inc. Earnings

EPS (ttm)$-0.36
Revenue (ttm)$655.41M
Revenue growth34.5%
Net margin-0.0%
Next earningsMay 5, 2026

Janus Living, Inc. Dividend

Annual dividend$0.57
Dividend yield222.00%
Ex-dividend dateJun 12, 2026

Analysts Set New Price Targets

ConsensusBuy
Average target$29.50
High target$34.00
Low target$26.00
Analysts covering10

About Janus Living, Inc.

Janus Living, Inc. is the only U.S. publicly traded REIT focused exclusively on the senior housing sector and the only U.S. publicly traded REIT. The firm's entire portfolio is owned and operated under RIDEA structures. The Firm's initial portfolio consisting of 34 senior housing communities, comprised of 10,422 units as of December 31, 2025. It's communities are located primarily in major retirement markets across 10 states, with units in Florida and Texas representing 69% of the total units as of December 31, 2025. All of the communities are owned and operated under RIDEA structures. Services provided by the operators under a RIDEA structure are primarily paid for directly by the residents, rather than governmental reimbursement programs, which provides with greater visibility into operating cash flow from our communities. Janus Living, Inc. is based in Denver, Colorado.

ExchangeNYSE
SectorReal Estate
IndustryREIT - Residential
HeadquartersDenver, CO
CEOMr. Scott M. Brinker

See Also

This instant news alert was generated by automated narrative technology and financial data from Opentrades and public regulatory filings. It is for informational purposes only and is not financial advice.